Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Neuropace, Inc. - Common Stock
(NQ:
NPCE
)
15.88
-0.31 (-1.91%)
Streaming Delayed Price
Updated: 2:19 PM EST, Dec 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neuropace, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
May 09, 2024
Via
Benzinga
NPCE Stock Earnings: NeuroPace Meets EPS, Beats Revenue for Q1 2024
↗
May 08, 2024
NPCE stock results show that NeuroPace met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
NeuroPace to Report First Quarter 2024 Financial Results on May 8, 2024
April 17, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
The Latest Analyst Ratings For NeuroPace
↗
March 12, 2024
Via
Benzinga
NPCE Stock Earnings: NeuroPace Beats EPS, Beats Revenue for Q4 2023
↗
March 05, 2024
NPCE stock results show that NeuroPace beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Recap: NeuroPace Q4 Earnings
↗
March 05, 2024
Via
Benzinga
Earnings Preview: NeuroPace
↗
March 04, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On NeuroPace Through 4 Analysts
↗
February 22, 2024
Via
Benzinga
NeuroPace Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
↗
January 30, 2024
Via
Benzinga
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
March 05, 2024
From
NeuroPace, Inc.
Via
GlobeNewswire
Financial Freedom Fighters: 3 Stocks to Liberate Your Portfolio
↗
March 05, 2024
Stocks for financial freedom are generational companies that are well-run, growing fast, and focused on the future.
Via
InvestorPlace
Earnings Scheduled For March 5, 2024
↗
March 05, 2024
Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via
Benzinga
Breaking Down NeuroPace: 6 Analysts Share Their Views
↗
December 27, 2023
Via
Benzinga
NeuroPace to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 19, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Leverage the Power of its RNS System’s Novel Data Collection, Brain Monitoring and Analysis Capabilities in Groundbreaking Collaboration
December 04, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Expert Ratings for NeuroPace
↗
December 04, 2023
Via
Benzinga
NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
December 01, 2023
RNS System featured in over 50 Scientific Presentations and Posters
From
NeuroPace, Inc.
Via
GlobeNewswire
Expert Ratings for NeuroPace
↗
November 10, 2023
Via
Benzinga
Earnings Scheduled For November 6, 2023
↗
November 06, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via
Benzinga
NeuroPace to Present at the Piper Sandler 35th Annual Healthcare Conference
November 21, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Epilepsy-Focused MedTech NeuroPace Has Attractive Entry Point, Competitive Position
↗
November 10, 2023
Cantor Fitzgerald initiated coverage on NeuroPace Inc (NASDAQ: NPCE), a commercial-stage medical device company focused on drug-resistant epilepsy treatment through the company's responsive...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
November 06, 2023
Via
Benzinga
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
November 06, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace Announces RNS System Enhancements Designed to Streamline Care
October 17, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Report Third Quarter 2023 Financial Results on November 6, 2023
October 16, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
September 20, 2023
From
NeuroPace, Inc.
Via
GlobeNewswire
Top 5 Health Care Stocks That May Fall Off A Cliff
↗
September 06, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
August 29, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 29, 2023
Via
Benzinga
Why Alpha Tau Medical Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
↗
August 29, 2023
Gainers Tivic Health Systems, Inc. (NASDAQ: TIVC) rose 62.4% to $3.15 in pre-market trading after falling 11% on Monday. Tivic Health Systems inked a pact to make its products available on...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today